Heron Therapeutics Inc vs Starbucks Corp — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while Starbucks Corp trades at $104.05 (market cap $119.45B). The key difference: Starbucks Corp is far larger — about 1306× Heron Therapeutics Inc's market cap, and Starbucks Corp pays a 2.37% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | SBUX | |
|---|---|---|
Market Cap | $91.46M | $119.45B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.96 | $108.37 |
52-Week Low | $0.39 | $78.46 |
Enterprise Value | $189.36M | $142.14B |
Volume | — | 7,493,833 |
Dividend Yield | — | 2.37% |
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →Starbucks Corporation retails, roasts, and provides its own brand of specialty coffee. The Company operates retail locations worldwide and sells whole bean coffees through its sales group, direct response business, supermarkets, and on the world wide web. Starbucks also produces and sells bottled coffee drinks and a line of ice creams.
Read more on SBUX →